Regeneron, US75886F1075

Regeneron stock heads into the open after a 0.31 percent gain.

Published on 09/18/2026 at 06:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 16, 2026, Regeneron stock finished at USD 777.00 on Nasdaq, up 0.31 percent. The Nasdaq Composite rose 1.69 percent, and Regeneron reports results on July 30, 2026, in the latest calendar hit.

Fotorealistisches Biotech-Labor mit Forschern und Pipetten an sterilen Arbeitsplätzen
Regeneron Pharma US75886F1075 zeigt ein fotorealistisches Biotech-Labor mit Forschern bei sorgfältigen Pipettierarbeiten am sterilen Steriltisch, Illustration mit AI erstellt.

Regeneron stock finished at USD 777.00 on Nasdaq on September 16, 2026, up 0.31 percent. The move came as the Nasdaq Composite rose 1.69 percent to 26,418.30 in the same session.

September 16, 2026 in numbers

Regeneron Pharmaceuticals, Inc. (ISIN US75886F1075) closed between USD 777.00 and USD 789.00 in the latest quoted session, with volume and a full day range not visible in the hit set. Reuters said the broader market closed higher as oil eased and Treasury yields dipped, with the Nasdaq Composite ending at 26,418.30.

Today before the open

The next reported quarterly earnings date in the hit set is July 30, 2026, and the calendar material in hand does not add a nearer dated event for today. MarketBeat also noted the companys last quarterly earnings release on July 30, 2026 and a dividend paid on August 31, 2026.

Disclaimer...

en | US75886F1075 | REGENERON | boerse | 70121992 | bgmi